What the FDA labels say about taking them together
Amisulpride and droperidol
Amisulpride's FDA label of June 17, 2026 names droperidol in its drug interactions section; the droperidol label PlainMeds reads does not name amisulpride. The amisulpride label: “Avoid use in patients with congenital long QT syndrome and in patients taking droperidol.”
Check it at the source: the amisulpride FDA label on DailyMed (effective June 17, 2026, Acacia Pharma Ltd); the droperidol FDA label on DailyMed (effective June 8, 2022, Hikma Pharmaceuticals USA Inc.).
What does the amisulpride label say about droperidol?
Amisulpride label, drug interactionsTo avoid potential additive effects, avoid use of BARHEMSYS in patients taking droperidol.
Amisulpride label, warnings and precautionsAvoid use in patients with congenital long QT syndrome and in patients taking droperidol.
Source: FDA drug label (Barhemsys), NDA209510 (Lxo Ireland), as published by Acacia Pharma Ltd, effective June 17, 2026 (SPL set ab23bc6e-b6a8-165f-e053-2a95a90ab144), via openFDA; the full label on DailyMed
What does the droperidol label say about amisulpride?
Droperidol's label (effective June 8, 2022) does not name amisulpride in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (DROPERIDOL), Hikma Pharmaceuticals USA Inc., effective June 8, 2022 (SPL set d89f33ac-8a6e-49e7-94fb-84e58aad65a8), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Amisulpride | Droperidol | |
|---|---|---|
| Labeled for | Nausea and vomiting | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once